Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Christina Brus"'
Autor:
Mirat Shah, Daniel L. Suzman, Mallorie H. Fiero, Danielle Krol, Amna Ibrahim, Laleh Amiri-Kordestani, Soma Ghosh, Christina Brus, Gwynn Ison, Tatiana M. Prowell, Shenghui Tang, Reena Philip, Sakar Wahby, Melanie Royce, Shaily Arora, Tara Berman, Julia A. Beaver, Jennifer J Gao, Preeti Narayan, Richard Pazdur, Suparna Wedam, Erik Bloomquist, Christy L. Osgood
Publikováno v:
Clin Cancer Res
Over the last decade, there has been tremendous progress in the treatment of patients with gynecologic cancers with a changing therapy landscape. This summary provides an overview of U.S. Food and Drug Administration (FDA) approvals for gynecologic c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0dd0d59d29d17c905da03926e5cca53d
https://europepmc.org/articles/PMC8923904/
https://europepmc.org/articles/PMC8923904/
Autor:
Christina Bruss, Veruschka Albert, Stephan Seitz, Stephanie Blaimer, Kerstin Kellner, Fabian Pohl, Olaf Ortmann, Gero Brockhoff, Anja K. Wege
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Pre-operative radiation therapy is not currently integrated into the treatment protocols for breast cancer. However, transforming immunological “cold” breast cancers by neoadjuvant irradiation into their “hot” variants is supposed to elicit a
Externí odkaz:
https://doaj.org/article/a00b7cc954714b9ba261cd27888f6f00
Autor:
Christina Brummer, Katrin Singer, Almut Brand, Christina Bruss, Kathrin Renner, Wolfgang Herr, Tobias Pukrop, Christoph Dorn, Claus Hellerbrand, Carina Matos, Marina Kreutz
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 15, p 8234 (2024)
Obesity is an emerging public health problem. Chronic low-grade inflammation is considered a major promotor of obesity-induced secondary diseases such as cardiovascular and fatty liver disease, type 2 diabetes mellitus, and several cancer entities. M
Externí odkaz:
https://doaj.org/article/fc3befb3233146e098ac9df39e21e6d6
Autor:
Veruschka Albert, Christina Bruss, Deniz Tümen, Gerhard Piendl, Florian Weber, Edgar Dahl, Stephan Seitz, Olaf Ortmann, Anja K. Wege, Gero Brockhoff
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 13, p 7475 (2024)
The impact of the HER4 receptor on the growth and treatment of estrogen receptor-positive breast cancer is widely uncertain. Using CRISPR/Cas9 technology, we generated stable HER4 knockout variants derived from the HER4-positive MCF-7, T-47D, and ZR-
Externí odkaz:
https://doaj.org/article/61e2188f6cf64a2d937a9fff9c763493
Autor:
Christian Schmidl, Wolfgang Herr, Nathalie Babl, Sonja-Maria Decking, Florian Voll, Michael Althammer, Ada Sala-Hojman, Roberta Ferretti, Clarissa Korf, Lisa Schmidleithner, Benedikt Nerb, Carina Matos, Gudrun E Koehl, Peter Siska, Christina Bruss, Fabian Kellermeier, Katja Dettmer, Peter J Oefner, Marvin Wichland, Ines Ugele, Christopher Bohr, Shivapriya Ramaswamy, Timo Heinrich, Christian Herhaus, Marina Kreutz, Kathrin Renner
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 10 (2023)
Background & Aims Intratumoral lactate accumulation and acidosis impair T-cell function and antitumor immunity. Interestingly, expression of the lactate transporter monocarboxylate transporter (MCT) 4, but not MCT1, turned out to be prognostic for th
Externí odkaz:
https://doaj.org/article/c03d167b710e4bcd97adb742f3e84064
Autor:
Robert Schoeppe, Nathalie Babl, Sonja-Maria Decking, Gabriele Schönhammer, Andreas Siegmund, Christina Bruss, Katja Dettmer, Peter J. Oefner, Linus Frick, Anna Weigert, Jonathan Jantsch, Wolfgang Herr, Michael Rehli, Kathrin Renner, Marina Kreutz
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionGlutamine deficiency is a well-known feature of the tumor environment. Here we analyzed the impact of glutamine deprivation on human myeloid cell survival and function.MethodsDifferent types of myeloid cells were cultured in the absence o
Externí odkaz:
https://doaj.org/article/f75ccd4777814a5299a61f9d76f85a60
Autor:
Christina, Brus, Muhammad Wasif, Saif
Publikováno v:
JOP : Journal of the pancreas. 11(4)
Most patients with adenocarcinoma of the pancreas present with locally advanced or metastatic disease. Although single agent gemcitabine is widely accepted as first-line therapy, there is no current standard of care for gemcitabine-refractory patient
Publikováno v:
Journal of Clinical Oncology. 33:277-277
277 Background: The oral MKI sorafenib has been shown to significantly increase PFS, OS and DCR in treatment-naïve HCC in randomized Ph 3 trials. Despite these landmark studies OS benefit is modest, particularly for those with C-P cirrhosis grades B
Publikováno v:
Journal of Pain and Symptom Management. 39:346-347
Autor:
Edith P. Mitchell, Nancy L. Lewis, Christina Brus, Agnieszka K. Witkiewicz, Erik S. Knudsen, Susan J. Littman, Madhavan V. Pillai, Terry Hyslop
Publikováno v:
Journal of Clinical Oncology. 31:321-321
321 Background: Hepatocellular carcinoma (HCC) is the 5th most common cancer worldwide and the 3rd most frequent cause of cancer-related mortality. Surgical resection & liver transplantation are the main curative options. Most patients present with a